Literature DB >> 23054442

Effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells (MSCs) in vitro.

Yi-Qun Lu1, Yan Lu, Hui-Juan Li, Xing-Bo Cheng.   

Abstract

This study aims to explore the effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells in vitro and the underlying mechanism. Bone marrow cell proliferation was determined by WST-8 assay using Cell Counting Kit-8 under the intervention of AGEs. In addition, the content of maldondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were also measured. The proliferation activity of mesenchymal stem cells (MSCs) was significantly inhibited when AGEs were added to culture medium, and this effect was dose-dependent and time-dependent. As the concentration of AGEs-bovine serum albumin increased, the content of intracellular MDA was significantly increased, but the activity of SOD in cell homogenates was significantly suppressed, which also showed a dose-dependent manner. AGEs could significantly inhibit the proliferation of MSCs in vitro by improving the oxidative stress in MSCs and breaking the homeostasis of intracellular environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054442     DOI: 10.1007/s11626-012-9551-7

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  22 in total

Review 1.  Advanced glycation end-products: a review.

Authors:  R Singh; A Barden; T Mori; L Beilin
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

Review 2.  Clinical review: The role of advanced glycation end products in progression and complications of diabetes.

Authors:  Su-Yen Goh; Mark E Cooper
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

Review 3.  Trafficking and differentiation of mesenchymal stem cells.

Authors:  Zhao-Jun Liu; Ying Zhuge; Omaida C Velazquez
Journal:  J Cell Biochem       Date:  2009-04-15       Impact factor: 4.429

Review 4.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

5.  Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.

Authors:  Shinichiro Kume; Seiya Kato; Sho-ichi Yamagishi; Yosuke Inagaki; Seiji Ueda; Nobuyuki Arima; Takahiro Okawa; Masamichi Kojiro; Kensei Nagata
Journal:  J Bone Miner Res       Date:  2005-05-23       Impact factor: 6.741

6.  Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.

Authors:  Chengbo Sun; Chun Liang; Yusheng Ren; Yi Zhen; Zhiqing He; Hua Wang; Hongbing Tan; Xiaoming Pan; Zonggui Wu
Journal:  Basic Res Cardiol       Date:  2008-07-11       Impact factor: 17.165

7.  Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.

Authors:  Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Hiroyoshi Inoue; Masayoshi Takeuchi; Seiji Ueda; Kei Fukami; Seiya Okuda; Tsutomu Imaizumi
Journal:  Microvasc Res       Date:  2007-05-18       Impact factor: 3.514

8.  Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.

Authors:  Lingyun Sun; Kentaro Akiyama; Huayong Zhang; Takayoshi Yamaza; Yayi Hou; Shengnan Zhao; Ting Xu; Anh Le; Songtao Shi
Journal:  Stem Cells       Date:  2009-06       Impact factor: 6.277

9.  Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.

Authors:  M Figliuzzi; R Cornolti; N Perico; C Rota; M Morigi; G Remuzzi; A Remuzzi; A Benigni
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

10.  Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.

Authors:  Ke Yang; Xiao Qun Wang; Yu Song He; Lin Lu; Qiu Jing Chen; Jing Liu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2010-10-22       Impact factor: 9.951

View more
  5 in total

1.  A rapid and efficient method for primary culture of human adipose-derived stem cells.

Authors:  Guofang Zeng; Kuan Lai; Jin Li; Yaqin Zou; Haili Huang; Jie Liang; Xudong Tang; Jing Wei; Peihua Zhang
Journal:  Organogenesis       Date:  2013-11-22       Impact factor: 2.500

Review 2.  The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review.

Authors:  Lize Evens; Hanne Beliën; Dorien Deluyker; Annelies Bronckaers; Pascal Gervois; Marc Hendrikx; Virginie Bito
Journal:  Stem Cells Int       Date:  2020-11-14       Impact factor: 5.443

3.  Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactions.

Authors:  Maryana Teufelsbauer; Clemens Lang; Adelina Plangger; Barbara Rath; Doris Moser; Clement Staud; Christine Radtke; Christoph Neumayer; Gerhard Hamilton
Journal:  Med Oncol       Date:  2022-02-12       Impact factor: 3.064

4.  Curcumin-incorporated 3D bioprinting gelatin methacryloyl hydrogel reduces reactive oxygen species-induced adipose-derived stem cell apoptosis and improves implanting survival in diabetic wounds.

Authors:  Sizhan Xia; Tingting Weng; Ronghua Jin; Min Yang; Meirong Yu; Wei Zhang; Xingang Wang; Chunmao Han
Journal:  Burns Trauma       Date:  2022-03-14

Review 5.  The Effect of Diabetes Mellitus on IGF Axis and Stem Cell Mediated Regeneration of the Periodontium.

Authors:  Nancy M S Hussein; Josie L Meade; Hemant Pandit; Elena Jones; Reem El-Gendy
Journal:  Bioengineering (Basel)       Date:  2021-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.